NTR
NYSE · Chemicals
Nutrien Ltd
$76.62
-0.20 (-0.26%)
Financial Highlights (FY 2026)
Revenue
33.94B
Net Income
880.81M
Gross Margin
28.4%
Profit Margin
2.6%
Rev Growth
-2.1%
D/E Ratio
0.52
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 28.4% | 28.4% | 46.8% | 46.8% |
| Operating Margin | 7.1% | 6.4% | 8.3% | 8.3% |
| Profit Margin | 2.6% | 2.5% | 8.6% | 8.1% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 33.94B | 34.68B | 24.90B | 24.03B |
| Gross Profit | 9.63B | 9.84B | 11.65B | 11.24B |
| Operating Income | 2.43B | 2.23B | 2.06B | 1.99B |
| Net Income | 880.81M | 810.07M | 2.14B | 1.94B |
| Gross Margin | 28.4% | 28.4% | 46.8% | 46.8% |
| Operating Margin | 7.1% | 6.4% | 8.3% | 8.3% |
| Profit Margin | 2.6% | 2.5% | 8.6% | 8.1% |
| Rev Growth | -2.1% | -2.1% | +14.2% | +8.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 8.01B | 8.01B | 6.63B | 6.41B |
| Total Equity | 15.27B | 15.27B | 20.37B | 20.87B |
| D/E Ratio | 0.52 | 0.52 | 0.33 | 0.31 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 3.67B | 3.57B | 2.29B | 2.51B |
| Free Cash Flow | — | — | 1.46B | 1.43B |